118 related articles for article (PubMed ID: 9782138)
1. Does preoperative treatment with a gonadotropin-releasing hormone agonist improve the outcome of endometrial resection?
Vercellin P; Perin A; Consonn R; Oldan S; Parazzini F; Crosignani PG
J Am Assoc Gynecol Laparosc; 1998 Nov; 5(4):357-60. PubMed ID: 9782138
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Sowter MC; Lethaby A; Singla AA
Cochrane Database Syst Rev; 2002; (3):CD001124. PubMed ID: 12137619
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: a multicentre, randomised controlled trial.
Vercellini P; Perino A; Consonni R; Trespidi L; Parazzini F; Crosignani PG
Br J Obstet Gynaecol; 1996 Jun; 103(6):562-8. PubMed ID: 8645650
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin releasing hormone agonist treatment before hysteroscopic endometrial resection.
Vercellini P; Trespidi L; Bramante T; Panazza S; Mauro F; Crosignani PG
Int J Gynaecol Obstet; 1994 Jun; 45(3):235-9. PubMed ID: 7926242
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative endometrial thinning agents before hysteroscopic surgery for heavy menstrual bleeding.
Sowter MC; Singla AA; Lethaby A
Cochrane Database Syst Rev; 2000; (2):CD001124. PubMed ID: 10796747
[TBL] [Abstract][Full Text] [Related]
7. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study.
Donnez J; Vilos G; Gannon MJ; Stampe-Sorensen S; Klinte I; Miller RM
Fertil Steril; 1997 Jul; 68(1):29-36. PubMed ID: 9207580
[TBL] [Abstract][Full Text] [Related]
8. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia.
Fraser IS; Healy DL; Torode H; Song JY; Mamers P; Wilde F
Obstet Gynecol; 1996 Apr; 87(4):544-50. PubMed ID: 8602306
[TBL] [Abstract][Full Text] [Related]
9. Pre- and postoperative therapy with GnRH agonist for endometrial resection. A prospective, randomized study.
Sørensen SS; Colov NP; Vejerslev LO
Acta Obstet Gynecol Scand; 1997 Apr; 76(4):340-4. PubMed ID: 9174428
[TBL] [Abstract][Full Text] [Related]
10. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial comparing GnRH antagonist cetrorelix with GnRH agonist leuprorelin for endometrial thinning prior to transcervical resection of endometrium.
Bhatia K; Doonan Y; Giannakou A; Bentick B
BJOG; 2008 Sep; 115(10):1214-24. PubMed ID: 18715405
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of severely symptomatic women with adenomyoma treated with combination therapy.
Liu WM; Chen CH; Chiu LH; Tzeng CR
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):85-9. PubMed ID: 23548225
[TBL] [Abstract][Full Text] [Related]
13. Cavaterm thermal balloon endometrial ablation versus hysteroscopic endometrial resection to treat menorrhagia: the French, multicenter, randomized study.
Brun JL; Raynal J; Burlet G; Galand B; Quéreux C; Bernard P
J Minim Invasive Gynecol; 2006; 13(5):424-30. PubMed ID: 16962526
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
Vercellini P; Bocciolone L; Colombo A; Vendola N; Meschia M; Bolis G
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):369-73. PubMed ID: 8392268
[TBL] [Abstract][Full Text] [Related]
15. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
[TBL] [Abstract][Full Text] [Related]
16. Hysteroscopic endometrial destruction, optimum method for preoperative endometrial preparation: a prospective, randomized, multicenter evaluation.
Shawki O; Peters A; Abraham-Hebert S
JSLS; 2002; 6(1):23-7. PubMed ID: 12002292
[TBL] [Abstract][Full Text] [Related]
17. Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation.
Khurana C; Taylor P; de Belder MA
Int J Cardiol; 1998 Jan; 63(1):89-91. PubMed ID: 9482151
[TBL] [Abstract][Full Text] [Related]
18. Relationship of endometrial thickness with the menstrual timing of leuprolide acetate administration for preoperative preparation for hysteroscopic surgery.
Nathanson HG; Phillips DR; Milim SJ; Haselkorn JS; Kapra A
J Am Assoc Gynecol Laparosc; 1997 Feb; 4(2):191-4. PubMed ID: 9050727
[TBL] [Abstract][Full Text] [Related]
19. Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri.
Candiani GB; Vercellini P; Fedele L; Arcaini L; Bianchi S; Candiani M
Acta Obstet Gynecol Scand; 1990; 69(5):413-5. PubMed ID: 2148663
[TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
Hawe J; Abbott J; Hunter D; Phillips G; Garry R
BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
